Cargando…
Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
Therapies based on immune cells have been applied for diseases ranging from cancer to diabetes. However, the viral and electroporation methods used to create cytoreagents are complex and expensive. Consequently, we develop targeted mRNA nanocarriers that are simply mixed with cells to reprogram them...
Autores principales: | Moffett, H. F., Coon, M. E., Radtke, S., Stephan, S. B., McKnight, L., Lambert, A., Stoddard, B. L., Kiem, H. P., Stephan, M. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577173/ https://www.ncbi.nlm.nih.gov/pubmed/28855514 http://dx.doi.org/10.1038/s41467-017-00505-8 |
Ejemplares similares
-
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
por: Zhang, F., et al.
Publicado: (2019) -
In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
por: Parayath, N. N., et al.
Publicado: (2020) -
“Hit-and-Run” transcription: de novo transcription initiated by a transient bZIP1 “hit” persists after the “run”
por: Doidy, Joan, et al.
Publicado: (2016) -
Hit‐and‐run trophallaxis of small hive beetles
por: Neumann, Peter, et al.
Publicado: (2015) -
Hit-and-run lymphomagenesis by the Bcl6 oncogene
por: Green, Michael R, et al.
Publicado: (2014)